Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCOPE: Oxytocin for Knee Osteoarthritis Pain in Older Adults
NCT03878589Phase 3Completed
- Sponsor
- University of Florida
- Start
- Aug 2019
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Phase 3, randomised trial of oxytocin nasal spray in knee osteoarthritis (OA) (2 arms), sponsored by University of Florida. Primary endpoint: Change in WOMAC Pain Score at 4 weeks. Started Aug 2019; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03878589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03878589.